๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Sofosbuvir - Medicines in Ireland

14 authorised products containing Sofosbuvir, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 14 authorised medicines
MedicineActive substanceLicence holderStatus
Epclusa 150 mg/37.5 mg coated granules in sachet
EU/1/16/1116/003
Sofosbuvir, Velpatasvir Gilead Sciences Ireland UC โ€”
Epclusa 200 mg/50 mg coated granules in sachet
EU/1/16/1116/004
Sofosbuvir, Velpatasvir Gilead Sciences Ireland UC โ€”
Epclusa 200 mg/50 mg film-coated tablets
EU/1/16/1116/002
Sofosbuvir Gilead Sciences Ireland UC โ€”
Epclusa 400 mg/100 mg film-coated tablets
EU/1/16/1116/001
Sofosbuvir, Velpatasvir Gilead Sciences Ireland UC โ€”
Harvoni 33.75 mg/150 mg Coated granules
EU/1/14/958/004
Ledipasvir, Sofosbuvir Gilead Sciences Ireland UC โ€”
Harvoni 45 mg/200 mg Coated granules
EU/1/14/958/005
Ledipasvir, Sofosbuvir Gilead Sciences Ireland UC โ€”
Harvoni 45 mg/200 mg Film-coated tablet
EU/1/14/958/003
Ledipasvir, Sofosbuvir Gilead Sciences Ireland UC โ€”
Harvoni 90 mg/400 mg Film-coated tablet
EU/1/14/958/001-002
Sofosbuvir, Ledipasvir Gilead Sciences Ireland UC โ€”
Sovaldi 150 mg coated granules in sachet
EU/1/13/894/004
Sofosbuvir Gilead Sciences Ireland UC โ€”
Sovaldi 200 mg coated granules in sachet
EU/1/13/894/005
Sofosbuvir Gilead Sciences Ireland UC โ€”
Sovaldi 200 mg film-coated tablets
EU/1/13/894/003
Sofosbuvir Gilead Sciences Ireland UC โ€”
Sovaldi 400 mg film-coated tablets
EU/1/13/894/001-002
Sofosbuvir Gilead Sciences Ireland UC โ€”
Vosevi 200 mg/50 mg/50 mg film-coated tablets
EU/1/17/1223/002
Sofosbuvir, Velpatasvir, Voxilaprevir Gilead Sciences Ireland UC โ€”
Vosevi 400 mg/100 mg/100 mg film-coated tablets
EU/1/17/1223/001
Sofosbuvir, Velpatasvir, Voxilaprevir Gilead Sciences Ireland UC โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.